Chief Operating Officer, Takeda Vaccines
Our full speaker panel can be found here
Professor, Biotechnology, Austrian Center of Industrial Biotechnology, University of natural resources and science
This exceptional speaker panel, assembled from leaders in biopharmaceutical drug production, will explore how realising the full potential of complex biotherapeutics and advanced therapies requires new technologies and strategies to produce these drugs. There will be a particular focus on overcoming bottlenecks within the manufacturing process, efficiency and maintaining high-quality standards.
As well as assessing the manufacturing processes and regulatory challenges for biologics, the Congress also features a track dedicated to the complex manufacturing of cell and gene therapies.
+ 40 presentations from industry and academic leaders
+ 7 hours of dedicated networking time
+ Expert-led roundtables and interactive panels
Table 1: CMO management – challenges & insights for outsourcing complex biologics
Led by: JENS LOHRMANN, Disease Area, Head Oncology, Technical R&D, Novartis
Table 2: Sharing Practices/Preferences with Sterile Filter Integrity Testing of Drug Product
Led by: KIRSTEN STRAHLENDORF, Senior Scientist, BioProcess R&D Formulation and Stability, Sanofi Pasteur